Search for: "JANSSEN PHARMACEUTICA INC" Results 1 - 20 of 50
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Sep 2008, 8:28 am
(Apotex) appeals the order of the United States District Court for the District of New Jersey dismissing its declaratory judgment action for noninfringement against Plaintiffs-Appellees Janssen Pharmaceutica, N.V. and Janssen, L.P. [read post]
15 Apr 2009, 8:56 pm
By Suresh Pillai -- Resolution Announced in Johnson & Johnson Razadyne ® ER Patent Litigation Johnson & Johnson units Janssen LP, Janssen Pharmaceutica NV, and Ortho-McNeil Neurologics have stipulated to a dismissal with prejudice of all claims of patent infringement against KV Pharmaceutical Co., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic version of Razadyne ® ER. [read post]
2 May 2011, 4:30 am by Laura Simons
A Spartanburg, South Carolina judge is set to decide how much money Janssen Pharmaceutica, Inc., a Johnson & Johnson subsidiary, should pay the state for what the jury found to be deceptive marketing by the company of its antipsychotic drug Risperdal. [read post]
18 Aug 2008, 3:48 am
Janssen Pharmaceutica N.V. et al. v. [read post]
13 Jun 2011, 4:30 am by Laura Simons
Earlier this month, the State of South Carolina was awarded $327 million in damages from drugmaker Janssen Pharmaceutica, Inc., a Johnson & Johnson subsidiary, under the state’s Unfair Trade Practices Act for deceptive marketing of its anti-psychotic drug, Risperdal.  [read post]
19 Nov 2008, 11:12 am
The suit alleged that the defendants, New Jersy based Janssen Pharmaceutica Inc. and California based ALZA Corp. knew about problems with the Duragesic patch that allowed it to leak fentanyl in doses large enough to kill pateints. [read post]
11 Nov 2008, 1:00 pm
Janssen Pharmaceutica Products and Alza, the subsidiaries, were responsible for the woman's death. [read post]
26 Mar 2013, 7:17 am by Brian A. Comer
South Carolina Lawyers Weekly ran an article last week concerning Janssen Pharmaceutica's appeal of a $327 million penalty handed down by Judge Robert Couch in 2011. [read post]
22 May 2014, 10:02 am by Majed Nachawati
September 11, 2003 the FDA notified Janssen Pharmaceutica, Inc. [read post]
7 Nov 2013, 11:24 pm by Jon Gelman
”Add caption Starr, a former sales representative for Janssen Pharmaceutica, a wholly-owned subsidiary of drugmaker Johnson & Johnson, felt as if she was being encouraged and pressured to market Risperdal off-label. [read post]
25 Mar 2014, 7:41 pm by FDABlog HPM
At trial against J&J, the State of Arkansas relied heavily on a 2004 Warning Letter issued to Janssen Pharmaceutica, Inc., the J&J unit responsible for marketing Risperdal, an antipsychotic drug. [read post]